In the LTP study, twelve weeks after final vaccination and at 3 months post-infection, only gp63 DNA immunization increased IgG2a titer by 2.3 fold and incorporation of CpG motifs to the gp63 DNA vaccination increased the titer by 2.56 fold (Table 2). The gene discussed is LMLN; the disease is infection.